Clinical Pharmacology

Episodes 1-16 of 16

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  0

  

  RestartResume

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  RestartResume

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  0.25 credits

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Vivek Subbiah, MD

    Peer

  2

  

  RestartResume

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  RestartResume

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  0.25 credits

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive …

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  3

  

  RestartResume

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  RestartResume

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  0.25 credits

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunothera…

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Sandip Patel, MD

    Peer

  1

  

  RestartResume

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  RestartResume

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  0.25 credits

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Ini…

  0.25 credits

• • 

    

    Madhukar H. Trivedi, MD

    Peer

  • 

    

    Steven Shoptaw, PhD

    Peer

  1

  

  RestartResume

  Evolving Pharmacologic Intervention for Methamphetamine Use Disorder: A Focus on ADAPT-2

  RestartResume

  Evolving Pharmacologic Intervention for Methamphetamine Use Disorder: A Focus on ADAPT-2

  0.25 credits

  Evolving Pharmacologic Intervention for Methamphetamine Use Disorder: A Focus o…

  0.25 credits
• 3

  

  RestartResume

  FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)

  RestartResume

  FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)

  FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lam…

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Meredith Wadman, BM, BCh, M.S.

    Peer

  6

  

  RestartResume

  The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease

  RestartResume

  The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease

  The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
• 3

  

  RestartResume

  FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

  RestartResume

  FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

  FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
• 0

  

  RestartResume

  Study Examines Effectiveness of Steroid Medication for Sore Throat

  RestartResume

  Study Examines Effectiveness of Steroid Medication for Sore Throat

  Study Examines Effectiveness of Steroid Medication for Sore Throat
• 5

  

  RestartResume

  Use of Statins for the Prevention of Cardiovascular Disease

  RestartResume

  Use of Statins for the Prevention of Cardiovascular Disease

  Use of Statins for the Prevention of Cardiovascular Disease
• 9

  

  RestartResume

  Reducing the High Cost of Prescription Drugs in the U.S.

  RestartResume

  Reducing the High Cost of Prescription Drugs in the U.S.

  Reducing the High Cost of Prescription Drugs in the U.S.
• 30

  

  RestartResume

  Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target

  RestartResume

  Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target

  Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-…
• 32

  

  RestartResume

  Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients

  RestartResume

  Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients

  Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solu…
• 8

  

  RestartResume

  Therapeutic Substitution Could Help Lower Prescription Drug Costs

  RestartResume

  Therapeutic Substitution Could Help Lower Prescription Drug Costs

  Therapeutic Substitution Could Help Lower Prescription Drug Costs
• 5

  

  RestartResume

  Long-Term Aspirin Use Associated with Decreased Cancer Risk

  RestartResume

  Long-Term Aspirin Use Associated with Decreased Cancer Risk

  Long-Term Aspirin Use Associated with Decreased Cancer Risk
• 6

  

  RestartResume

  Combination Drug Treatment Reduces Agitation in Patients with Alzheimer's Disease

  RestartResume

  Combination Drug Treatment Reduces Agitation in Patients with Alzheimer's Disease

  Combination Drug Treatment Reduces Agitation in Patients with Alzheimer's Disea…